J.P. Morgan analyst David Adlington maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) today and set ...

In a report released today, Graham Doyle from UBS maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research ...

Blue Trust Inc. grew its stake in Fresenius Medical Care AG (NYSE:FMS – Free Report) by 15.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 14,876 shares of the ...

DelveInsight's Artificial Kidney Market Insights report provides the current and forecast market analysis, individual leading ...

Fresenius Medical Care has seen 18.5% growth, with strong prospects. Learn why FMS stock’s fair value of $34/share makes it a solid “Buy” opportunity.

Aurora™ is the automated system that streamlines plasma collection, producing virtually cell-free plasma and providing an improved experience for both operators and donors. The system separates ...

UHS Universal Health Services, Inc.